ArticleFrontiers in neurology2025
Predictive value of temporal muscle thickness in patients with chronic subdural hematoma.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic subdural hematoma (CSDH) is a common neurosurgical condition that predominantly affects elderly individuals and is characterized by the accumulation of blood between the dura mater and the brain surface. Temporal muscle thickness (TMT) has emerged as a potential prognostic marker for various neurological diseases, including CSDH. This study aimed to evaluate the prognostic value of TMT in patients with CSDH. Methods: This retrospective study assessed TMT in patients with CSDH using cranial CT scans. We examined the correlation between TMT and CSDH-related clinical characteristics and evaluated the prognostic relevance of TMT. Results: A total of 844 participants were included in the study. TMT was significantly lower in patients with CSDH than in the control group ( Conclusion: The occurrence of CSDH is significantly correlated with the side of lower TMT. TMT may serve as an important prognostic marker in patients with CSDH, particularly for predicting functional outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.